The Pelvic Floor Function and Sexual Life of the Women After Different Type of Hysterectomy (HYS-PF-QOL)
The Association of Total Hysterectomy and Disorders of Female Pelvic Floor or Sexual Function: a Survey on Pelvic Floor Function and Sexual Life for Women After Different Type of Hysterectomy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Chiayi, Taiwan, 62224
- Dalin Tzu Chi Hospital
-
Hualien, Taiwan, 970
- Buddhist Tzu Chi General Hospital
-
Hualien, Taiwan, 970
- Mennonite Memorial Hospital
-
Taipei, Taiwan, 23142
- Taipei Tzu Chi Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient who is indicated for hysterectomy due to benign gynecology disease. The participant's husband is also welcomed to join the survey of the sexual life questionnaire but this is not a necessary inclusion criteria.
Exclusion Criteria:
- Suspect of or diagnosed as cancer patient
- Age < 30 or > 50 years old
- Menopausal woman or woman who is nulliparous
- Patient with advanced pelvic floor prolapse (stage 2, 3, 4) including uterine prolapse, cystocele, enterocele, rectocele.
- Patient with prominent urinary incontinence that affect social activity or suggested to have surgery by gynecologist or urologist.
- Patient with severe medical diseases such as liver cirrhosis, heart failure, poor control diabetes mellitus etc.
- Patient with severe pelvic inflammatory disease/tubo-ovarian abcess or pelvic endometriosis or history of severe pelvic adhesions.
- Psychiatric patients
- Patient with chronic lung disease such as bronchial asthma, bronchiectasis, chronic obstructive pulmonary disease and interstitial lung disease
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Laparoscopic subtotal hysterectomy
women with benign gynecology disease and decided to receive laparoscopic subtotal hysterectomy (LSH) after discussion with her surgeon.
|
laparoscopic subtotal hysterectomy: LSH
Other Names:
|
|
Laparoscopic CLSH
women with benign gynecology disease and decided to receive laparoscopic cervical ligament sparing hysterectomy (CLSH) after discussion with her surgeon.
|
laparoscopic cervical ligament sparing hysterectomy: CLSH
|
|
Laparoscopic AVH
women with benign gynecology disease and decided to receive laparoscopic assisted vaginal hysterectomy (LAVH) after discussion with her surgeon.
|
laparoscopic assisted vaginal hysterectomy: LAVH
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life change
Time Frame: up to 12 months after hysterectomy
|
Evaluate the change of quality of life by questionaire --WHOQOL-BREF Taiwan version, at preoperation,1,3,6 and 12 months after hysterectomy.
|
up to 12 months after hysterectomy
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pelvic organ prolapse change
Time Frame: up to 24 months after hysterectomy
|
evaluate by Pelvic Organ Prolapse Quantification System (POP-Q) at preoperation, 6,12 and 24 months after hysterectomy.
|
up to 24 months after hysterectomy
|
|
Urinary disorders change
Time Frame: preoperation and 3,6 and 12 months after hysterectomy
|
evaluate by UDI-6 short form at preoperation,3,6 and 12 months after hysterectomy.
|
preoperation and 3,6 and 12 months after hysterectomy
|
|
Sexual life change
Time Frame: preoperation and 3,6 and 12 months after hysterectomy
|
short form of PISQ-9 approved by International Urogynecological Association, IUGA, at preoperation,3,6 and 12 months after hysterectomy.
|
preoperation and 3,6 and 12 months after hysterectomy
|
|
Urinary incontinence status change
Time Frame: preoperation and 3,6 and 12 months after hysterectomy
|
evaluate by IIQ-7 short form at preoperation,3,6 and 12 months after hysterectomy.
|
preoperation and 3,6 and 12 months after hysterectomy
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Mun-Kun Hong, MD, Department of Obstetrics and Gynecology
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HYS-SEX-QOL-POP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.